Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00233675

Public ClinicalTrials.gov record NCT00233675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 3:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety of GABITRIL at Dosages up to 16mg/Day in Adults With Generalized Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).

Study identification

NCT ID
NCT00233675
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2003
Primary completion
Jan 31, 2005
Completion
Not listed
Last update posted
Apr 11, 2023

Started 2003

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Pivotal Research Center Mesa Arizona 85210
Southwestern Research Beverly Hills California 90210
Pharmacology Research Institut Newport Beach California 92660
Pharmacology Research Institut Northridge California 91324
Pacific Clinical Research Medi Orange California 92868
Radiant Research San Diego San Diego California 92103
Affiliated Research Institute San Diego California 92108
Radiant Research Denver Denver Colorado 80212
University of Connecticut Farmington Connecticut 06030
Clinical Neuroscience Solution Jacksonville Florida 32216
Clinical Neuroscience Solution West Palm Beach Florida 33407
Carman Research Smyrna Georgia 30080
Cunningham Clinical Research Edwardsville Illinois 62025
Massachusetts General Hospital Boston Massachusetts 02114
Summit Research Network Farmin Farmington Hills Michigan 48336
CNS Research Institute Clementon New Jersey 08021
Social Psychiatry Research Ins Brooklyn New York 11235
Fieve Clinical Services, Inc. New York New York 10021
Medical and Behavioral New York New York 10023
Medical Research Network New York New York 10024
Richard Weisler, MD and Assoc Raleigh North Carolina 27609
Summit Research Network Inc. Portland Oregon 97210
University of Pennsylvania Philadelphia Pennsylvania 19104
South East Health Consultants Charleston South Carolina 29407
Claghorn-Lesem Research Bellaire Texas 77401
Radiant Research Salt Lake Salt Lake City Utah 84107
Comprehensive Neuroscience Of Falls Church Virginia 22041
Summit Seattle Boren Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00233675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00233675 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →